GE offers off-the-shelf manufacturing plants; Valeant, Medicis combine operations;

> GE Healthcare is now selling what it calls KUBio, an off-the-shelf, 1,200-square-meter modular factory that can be quickly erected and ready to manufacture. Story

> GeneTex, the U.S. antibody producer, says it will make a new antibody against HIF1a (hypoxia-inducible factor 1alpha) that is more stable than many on the market. Item

> Under new rules in Denmark, drug manufacturers' authorization to do business will not have to be updated but will be considered valid unless regulators take steps to change them. Story

> Valeant Pharmaceuticals ($VRX) is buying dermatology specialist Medicis Pharmaceuticals for $2.6 billion. Story

And Finally... More than 50 years after its morning sickness drug Thalidomide was banned because it causes deformities in children whose mothers took it, the German drugmaker Grunenthal has apologized for its effects. Story

Suggested Articles

Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.